Literature DB >> 16375971

Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization.

T Allice1, S Scutera, M G Chirillo, D Savoia.   

Abstract

OBJECTIVES: To characterize by molecular techniques Burkholderia strains responsible for respiratory tract infections in cystic fibrosis (CF) patients (children and adults), to assign the Burkholderia cepacia complex (Bcc) isolates to a genomovar and to assess the presence of cblA and esmR genes in bacteria. Unique or sequential Burkholderia isolates (n=48) that had been collected from eight CF children and 17 adults over several (4-6) years were investigated; moreover 11 reference strains were analyzed.
METHODS: The microorganisms were identified by using biochemical methods, genotyped by pulse field gel electrophoresis (PFGE) and random-amplified polymorphic DNA fingerprinting-PCR (RAPD-PCR), and assessed by PCR assays for the genomovar and cblA and esmR genes of Bcc.
RESULTS: Among isolates 70.8% were identified as Bcc genomovar III-A; one child was infected by Burkholderia ambifaria and four adults were colonized with Burkholderia gladioli. The cblA gene was not detected in any of the isolates, while the esmR gene was detected in the 52.1% of the strains, all belonging to genomovar III-A.
CONCLUSION: Molecular analysis of strains revealed in CF patients a colonization with a persistent Burkholderia flora with strains of one genotype. The prevalence of Bcc of genomovar III-A in the two categories of patients and of B. gladioli in four adults demonstrated that transmission may have occurred between subjects. Moreover the B. ambifaria infection demonstrated in a child may be environmentally derived.

Entities:  

Mesh:

Year:  2006        PMID: 16375971     DOI: 10.1016/j.jinf.2005.11.005

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.

Authors:  G Marioni; R Rinaldi; C Staffieri; G Ottaviano; R Marchese-Ragona; L Giacomelli; S M Ferraro; A Staffieri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-01       Impact factor: 3.267

2.  Burkholderia gladioli infection isolated from the blood cultures of newborns in the neonatal intensive care unit.

Authors:  F Zhou; H Ning; F Chen; W Wu; A Chen; J Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-30       Impact factor: 3.267

3.  Clinical and environmental Burkholderia strains: biofilm production and intracellular survival.

Authors:  Dianella Savoia; Mario Zucca
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

4.  Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  I Leone; M G Chirillo; T Raso; M Zucca; D Savoia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-17       Impact factor: 3.267

5.  Two cases of keratitis and corneal ulcers caused by Burkholderia gladioli.

Authors:  Franka Lestin; Robert Kraak; Andreas Podbielski
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

6.  Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.

Authors:  Priscila Dentini; Fernando Augusto Lima Marson; Luciana Cardoso Bonadia; Carmen Sílvia Bertuzzo; Antônio Fernando Ribeiro; Carlos Emílio Levy; José Dirceu Ribeiro
Journal:  Med Microbiol Immunol       Date:  2017-09-30       Impact factor: 3.402

7.  Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.

Authors:  M J Medina-Pascual; S Valdezate; P Villalón; N Garrido; V Rubio; J A Saéz-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-02       Impact factor: 3.267

8.  Sphingobacterium respiratory tract infection in patients with cystic fibrosis.

Authors:  Antonietta Lambiase; Fabio Rossano; Mariassunta Del Pezzo; Valeria Raia; Angela Sepe; Fabiola de Gregorio; Maria Rosaria Catania
Journal:  BMC Res Notes       Date:  2009-12-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.